Interleukin-8-positive neutrophils in psoriasis.

[1]  C. Akdis,et al.  T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. , 1999, The Journal of investigative dermatology.

[2]  G. Huang,et al.  Increased interleukin-8 expression in inflamed human dental pulps. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[3]  M. Sticherling,et al.  Interleukin-8 plays its role at local level in psoriasis vulgaris. , 1999, Acta dermato-venereologica.

[4]  Y. Yonemitsu,et al.  The proliferative properties of tumor cells differentially correlate with the host immune responses in anogenital Bowen's disease. , 1999, Journal of dermatological science.

[5]  A. Gougeon,et al.  Evidence for a neutrophil-interleukin-8 system in human folliculogenesis. , 1998, American journal of obstetrics and gynecology.

[6]  Haas,et al.  Neutrophilic urticaria: clinical features, histological changes and possible mechanisms , 1998, The British journal of dermatology.

[7]  H. Müller-Hermelink,et al.  Inflammatory infiltrate and interleukin-8 expression in the synovium of psoriatic arthritis – an immunohistochemical and mRNA analysis , 1997, Rheumatology International.

[8]  M. Duvic,et al.  Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. , 1996, The Journal of investigative dermatology.

[9]  A. Thomson,et al.  IL‐8/IL‐8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy , 1995, Clinical and experimental immunology.

[10]  D. Blanchard,et al.  Induction of IL-8 gene expression in human polymorphonuclear neutrophils by recombinant IL-2. , 1994, Journal of immunology.

[11]  F. S. Becker,et al.  Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. , 1993, Journal of immunology.

[12]  J. Singer,et al.  Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. , 1993, Blood.

[13]  H. Tagami,et al.  Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. , 1993, Archives of dermatology.

[14]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[15]  M. Baggiolini,et al.  Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. , 1992, The Journal of investigative dermatology.

[16]  K. Wolff,et al.  Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. , 1991, The Journal of investigative dermatology.

[17]  B. Dewald,et al.  Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8 , 1991, The Journal of experimental medicine.

[18]  James T. Elder,et al.  Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. , 1991, The American journal of pathology.

[19]  M. Sticherling,et al.  Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. , 1991, The Journal of investigative dermatology.

[20]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.